Article Information
- Received October 4, 2012
- Revision received January 17, 2013
- Accepted February 12, 2013
- First published March 20, 2013.
- Version of record published March 20, 2013.
Author Information
- Graziana Gatto1,
- Irina Dudanova1,
- Philipp Suetterlin2,
- Alun M. Davies3,
- Uwe Drescher2,
- John L. Bixby4, and
- Rüdiger Klein1
- 1Department of Molecules–Signaling–Development, Max Planck Institute of Neurobiology, D-82152, Martinsried, Germany,
- 2Medical Research Council Centre for Developmental Neurobiology, King's College London, SE1 1UL, London, United Kingdom,
- 3School of Biosciences, CF10 3AT, Cardiff, United Kingdom, and
- 4Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida 33136
Author contributions
Author contributions: G.G., A.M.D., U.D., and R.K. designed research; G.G., I.D., and P.S. performed research; J.L.B. contributed unpublished reagents/analytic tools; G.G., I.D., P.S., and U.D. analyzed data; G.G., J.L.B., and R.K. wrote the paper.
Disclosures
- Received October 4, 2012.
- Revision received January 17, 2013.
- Accepted February 12, 2013.
This study was supported by the Max Planck Society, the European Union [MOLPARK (Molecular mechanisms of neuronal restoration: novel approaches for Parkinson's disease)], the German Research Foundation (Collaborative Research Centre 870), the National Institutes of Health, and the Wellcome Trust. We thank L. Gaitanos for technical assistance, D. Marinescu and S. Krinner for mouse genotyping, A. Huber-Brösamle, T. Matozaki, and Eek-hoon Jho for kindly providing reagents, and T. Gaitanos, P. Klein, and S. Paixão for fruitful discussions.
The authors declare no competing financial interests.
- Correspondence should be addressed to Rüdiger Klein, Department of Molecules–Signaling–Development, Max Planck Institute of Neurobiology, Am Klopferspitz 18A, D-82152, Martinsried, Germany. rklein{at}neuro.mpg.de
Statistics from Altmetric.com
Article usage
In this issue
